HRP20180452T1 - Peptidi - Google Patents

Peptidi

Info

Publication number: HRP20180452T1
Authority: HR; Croatia
Prior art keywords: peptides
Prior art date: 2013-08-06

Application number

HRP20180452TT

Other languages

English (en)

Inventor

David Wraith

Original Assignee

Apitope International Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-08-06

Filing date

2014-08-06

Publication date

2018-06-01

2014-08-06 Application filed by Apitope International Nv filed Critical Apitope International Nv

2018-06-01 Publication of HRP20180452T1 publication Critical patent/HRP20180452T1/hr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Cell Biology (AREA)
Microbiology (AREA)
Mycology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

HRP20180452TT 2013-08-06 2014-08-06 Peptidi HRP20180452T1 (hr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB201314052A GB201314052D0 (en)	2013-08-06	2013-08-06	Peptides
EP14772444.7A EP3030259B1 (en)	2013-08-06	2014-08-06	Peptides
PCT/IB2014/063739 WO2015019302A2 (en)	2013-08-06	2014-08-06	Peptides

Publications (1)

Publication Number	Publication Date
HRP20180452T1 true HRP20180452T1 (hr)	2018-06-01

Family

ID=49224229

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HRP20180452TT HRP20180452T1 (hr)	2013-08-06	2014-08-06	Peptidi

Country Status (32)

Country	Link
US (2)	US9938329B2 (hr)
EP (1)	EP3030259B1 (hr)
JP (1)	JP6476181B2 (hr)
KR (1)	KR102431507B1 (hr)
CN (1)	CN105636980B (hr)
AU (1)	AU2014304108B2 (hr)
BR (1)	BR112016002572A2 (hr)
CA (1)	CA2920321C (hr)
CY (1)	CY1120212T1 (hr)
DK (1)	DK3030259T3 (hr)
ES (1)	ES2664045T3 (hr)
GB (1)	GB201314052D0 (hr)
HR (1)	HRP20180452T1 (hr)
HU (1)	HUE038569T2 (hr)
IL (1)	IL243892B (hr)
LT (1)	LT3030259T (hr)
MX (1)	MX369412B (hr)
MY (1)	MY177371A (hr)
NO (1)	NO3030259T3 (hr)
NZ (1)	NZ717350A (hr)
PE (1)	PE20160778A1 (hr)
PH (1)	PH12016500218A1 (hr)
PL (1)	PL3030259T3 (hr)
PT (1)	PT3030259T (hr)
RS (1)	RS57196B1 (hr)
RU (1)	RU2676149C2 (hr)
SG (1)	SG11201600895SA (hr)
SI (1)	SI3030259T1 (hr)
SM (1)	SMT201800153T1 (hr)
UA (1)	UA120746C2 (hr)
WO (1)	WO2015019302A2 (hr)
ZA (1)	ZA201600729B (hr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201314052D0 (en) *	2013-08-06	2013-09-18	Apitope Int Nv	Peptides
SG11201705020VA (en) *	2014-12-24	2017-07-28	Apitope Int Nv	Composition
EP3565585B1 (en) *	2017-01-04	2024-11-13	Worg Pharmaceuticals (Zhejiang) Co., Ltd.	Therapeutic method using dose escalation protocol for tolerogenic peptides
EP3369743A1 (en) *	2017-03-01	2018-09-05	advanceCOR GmbH	Cyclic peptides for the treatment of graves' disease
EP3622962A1 (en)	2018-09-14	2020-03-18	advanceCOR GmbH	Short cyclic peptides for the treatment of graves' disease
KR20220062488A (ko) *	2019-06-12	2022-05-17	바이오엔테크 유에스 인크.	신생항원 조성물 및 이의 용도
GB201909774D0 (en)	2019-07-08	2019-08-21	Apitope Tech Bristol Limited	Method
GB201919222D0 (en) *	2019-12-23	2020-02-05	Apitope Int Nv	Composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2092998T3 (es)	1989-12-14	1996-12-16	Brahms Diagnostica Gmbh	Polipeptidos que tienen actividad de receptores de tirotropina, secuencias de acidos nucleicos que codifican para tales receptores y polipeptidos, y aplicaciones de estos polipeptidos.
AU7863701A (en) *	2000-08-21	2002-03-04	Univ Bristol	Peptide selection method
GB0202399D0 (en)	2002-02-01	2002-03-20	Univ Bristol	Peptide
FR2842812A1 (fr) *	2002-07-26	2004-01-30	Pf Medicament	Procede de solubilisation de peptides hydrophobes et leur utilisation pour generer une reponse de type ctl antitumorale ou anti-infectueuse
JP2006188507A (ja) *	2004-12-10	2006-07-20	Tokyo Univ Of Agriculture & Technology	蛋白質の溶解度向上方法
EP1951753A2 (en) *	2005-11-21	2008-08-06	Dr. Fenning Biomed GmbH	Recombinant polypeptides and methods for detecting and/or quantifying autoantibodies against tsh receptor
TWI414531B (zh) *	2006-10-12	2013-11-11	Genentech Inc	淋巴毒素α之抗體
GB0723712D0 (en)	2007-12-04	2008-01-16	Apitope Technology Bristol Ltd	Peptides
GB0908515D0 (en) *	2009-05-18	2009-06-24	Apitope Technology Bristol Ltd	Peptide
GB201314052D0 (en) *	2013-08-06	2013-09-18	Apitope Int Nv	Peptides

2013
- 2013-08-06 GB GB201314052A patent/GB201314052D0/en not_active Ceased
2014
- 2014-08-06 SG SG11201600895SA patent/SG11201600895SA/en unknown
- 2014-08-06 NZ NZ717350A patent/NZ717350A/en unknown
- 2014-08-06 WO PCT/IB2014/063739 patent/WO2015019302A2/en not_active Ceased
- 2014-08-06 CN CN201480053788.0A patent/CN105636980B/zh active Active
- 2014-08-06 LT LTEP14772444.7T patent/LT3030259T/lt unknown
- 2014-08-06 ES ES14772444.7T patent/ES2664045T3/es active Active
- 2014-08-06 MX MX2016001744A patent/MX369412B/es active IP Right Grant
- 2014-08-06 RU RU2016107873A patent/RU2676149C2/ru active
- 2014-08-06 DK DK14772444.7T patent/DK3030259T3/en active
- 2014-08-06 CA CA2920321A patent/CA2920321C/en active Active
- 2014-08-06 US US14/910,372 patent/US9938329B2/en active Active
- 2014-08-06 KR KR1020167005185A patent/KR102431507B1/ko active Active
- 2014-08-06 HU HUE14772444A patent/HUE038569T2/hu unknown
- 2014-08-06 PT PT147724447T patent/PT3030259T/pt unknown
- 2014-08-06 PL PL14772444T patent/PL3030259T3/pl unknown
- 2014-08-06 HR HRP20180452TT patent/HRP20180452T1/hr unknown
- 2014-08-06 BR BR112016002572A patent/BR112016002572A2/pt not_active IP Right Cessation
- 2014-08-06 NO NO14772444A patent/NO3030259T3/no unknown
- 2014-08-06 PE PE2016000223A patent/PE20160778A1/es unknown
- 2014-08-06 JP JP2016532780A patent/JP6476181B2/ja active Active
- 2014-08-06 SM SM20180153T patent/SMT201800153T1/it unknown
- 2014-08-06 MY MYPI2016000224A patent/MY177371A/en unknown
- 2014-08-06 EP EP14772444.7A patent/EP3030259B1/en active Active
- 2014-08-06 UA UAA201602098A patent/UA120746C2/uk unknown
- 2014-08-06 RS RS20180316A patent/RS57196B1/sr unknown
- 2014-08-06 SI SI201430666T patent/SI3030259T1/en unknown
- 2014-08-06 AU AU2014304108A patent/AU2014304108B2/en active Active
2016
- 2016-02-01 PH PH12016500218A patent/PH12016500218A1/en unknown
- 2016-02-01 IL IL24389216A patent/IL243892B/en active IP Right Grant
- 2016-02-02 ZA ZA2016/00729A patent/ZA201600729B/en unknown
2018
- 2018-02-23 US US15/903,379 patent/US10730919B2/en active Active
- 2018-03-26 CY CY20181100337T patent/CY1120212T1/el unknown

Also Published As

Publication number	Publication date
WO2015019302A3 (en)	2015-08-27
US20160185833A1 (en)	2016-06-30
CA2920321A1 (en)	2015-02-12
PH12016500218A1 (en)	2016-04-25
DK3030259T3 (en)	2018-04-16
AU2014304108B2 (en)	2018-03-08
PL3030259T3 (pl)	2018-07-31
LT3030259T (lt)	2018-05-10
CA2920321C (en)	2022-10-18
KR20160036059A (ko)	2016-04-01
CN105636980B (zh)	2021-05-04
RS57196B1 (sr)	2018-07-31
MY177371A (en)	2020-09-14
MX2016001744A (es)	2016-05-18
HUE038569T2 (hu)	2018-10-29
ES2664045T3 (es)	2018-04-18
KR102431507B1 (ko)	2022-08-10
UA120746C2 (uk)	2020-02-10
JP2016527304A (ja)	2016-09-08
HK1219058A1 (en)	2017-03-24
US20180327463A1 (en)	2018-11-15
SG11201600895SA (en)	2016-03-30
GB201314052D0 (en)	2013-09-18
NO3030259T3 (hr)	2018-05-26
AU2014304108A1 (en)	2016-02-25
JP6476181B2 (ja)	2019-02-27
ZA201600729B (en)	2019-12-18
US10730919B2 (en)	2020-08-04
RU2676149C2 (ru)	2018-12-26
SMT201800153T1 (it)	2018-05-02
NZ717350A (en)	2019-03-29
CY1120212T1 (el)	2018-12-12
US9938329B2 (en)	2018-04-10
PT3030259T (pt)	2018-03-20
PE20160778A1 (es)	2016-08-06
RU2016107873A (ru)	2017-09-12
BR112016002572A2 (pt)	2017-09-12
EP3030259A2 (en)	2016-06-15
WO2015019302A2 (en)	2015-02-12
EP3030259B1 (en)	2017-12-27
CN105636980A (zh)	2016-06-01
IL243892B (en)	2019-11-28
MX369412B (es)	2019-11-07
IL243892A0 (en)	2016-04-21
SI3030259T1 (en)	2018-07-31

Publication	Publication Date	Title
NO2025054I1 (no)	2025-12-08	Zanidatamab
NL301345I2 (nl)	2025-11-05	datopotamab deruxtecan
NL301252I2 (nl)	2024-01-04	tislelizumab
NL301272I2 (nl)	2024-06-24	Fezolinetant
NO2021043I1 (no)	2021-09-28	dostarlima
CL2015003031A1 (es)	2016-06-24	Compuesto peptídico
DK2951203T3 (da)	2019-08-12	Heterodimere proteiner
DK3342773T3 (da)	2021-02-15	Syk-hæmmere
DK3613453T3 (da)	2021-10-11	Fordamper
DK3041857T3 (da)	2019-07-22	Protein a-kromatografi
DK3077047T3 (da)	2019-07-15	Aramcholsalte
DK3052081T3 (da)	2021-01-18	Pastil
DK3060460T3 (da)	2021-04-19	Saddel
DK3027598T3 (da)	2017-05-22	Oxoquinazolinyl-butanamidderivater
DK2956698T3 (da)	2021-02-08	Bindestrimler
LT3030259T (lt)	2018-05-10	Peptidai
DK2946640T3 (da)	2017-11-20	Langmuir-probe
EP2943489A4 (en)	2016-06-08	DEUTERATED MOMELOTINIB
DE102013106534B8 (de)	2015-06-18	Chromatographiepipettenspitze
EP2991647A4 (en)	2016-10-12	DEUTERED AMLEXANOX
EP2970310A4 (en)	2016-09-07	5-BROMO-indirubins
EP2853297A4 (en)	2016-02-24	kendama
DK3071227T3 (da)	2021-01-18	Fiskevaccine
DE112014001252A5 (de)	2016-01-21	Aufbissschiene
DK2983690T3 (da)	2019-05-20	Neuropeptid Y-afledte peptider